15 Biggest Mid-Day Gainers For Tuesday - ACADIA Pharmaceuticals (NASDAQ:ACAD), Addus HomeCare (NASDAQ:ADUS)

Osiris Therapeutics, Inc. OSIR shares climbed 25.8 percent to $5.27. Osiris Therapeutics expects that 2014 will restate revenue to $46 million-$50 million. The company projects 2015 revenue of $85 million to $90 million and FY16 revenue of$100 million to $110 million.
Earthstone Energy Inc ESTE rose 21.3 percent to $10.89 after earlier announcement of strategic combination with Bold Energy III LLC. The company also announced Q3 results.
ACADIA Pharmaceuticals Inc. ACAD shares surged 18.7 percent to $27.28. Acadia Pharmaceuticals reported a Q3 loss of $71.6 million on revenue of $5.3 million.
NL Industries Inc NL rose 18.3 percent to $4.20. NL Industries reported Q3 profit of $7.4 million on revenue of $28.4 million.
Kronos Worldwide, Inc. KRO climbed 16.2 percent to $9.31 on better-than-expected Q3 earnings.
iCAD Inc ICAD rose 13.7 percent to $3.24. iCAD named Richard Christopher as Executive Vice President and Chief Financial Officer.
IAMGOLD Corp (USA) IAG gained 7.7 percent to $4.28 after reporting better-than-expected Q3 earnings.
Johnson Controls International plc JCI shares rose 5.5 percent to $43.84 as the company reported better-than-expected Q4 results.
Priceline Group Inc PCLN gained 6.7 percent to $1,580.00 after the company reported stronger-than-expected earnings for its third quarter. The firm’s interim CEO, Brett Keller, has been named Chief Executive Officer of Priceline.com, and will respond to the company’s Interim CEO and Chairman of the Board Jeffery H. Boyd.
Stone Energy Corporation SGY shares climbed 28.1 percent to $5.15 following Q3 results. Stone Energy reported a Q3 adjusted loss of $7.40 per share.
Addus Homecare Corporation ADUS shares rose 15 percent to $29.90 after the company posted strong Q3 results.
Synchronoss Technologies, Inc. SNCR shares climbed 13.2 percent to $44.91 after the company posted better-than-expected Q3 earnings.
500.com Ltd WBAI shares gained 10 percent to $13.45. 500.com is affirming normal operation of its business and will resume its $30 million buyback plan. The company is scheduled to report Q3 financial results on November 10, 2016.
ACADIA Pharmaceuticals Inc. ACAD shares surged 17.5 percent to $27.02. Acadia Pharmaceuticals reported a Q3 loss of $71.6 million on revenue of $5.3 million.
Fabrinet FN shares rose 4 percent to $40.32. Fabrinet posted better-than-expected Q1 results.

Market News and Data brought to you by Benzinga APIs